Question 1

What is CommonQuant (Common Quant)?

Accepted Answer

CommonQuant, also written Common Quant, is an AI-powered trading platform that turns plain-English market ideas into live, rules-based strategies. It selects relevant instruments, writes indicator-based entry and exit rules, monitors the conditions continuously, and alerts users when conditions are met.

Question 2

How does CommonQuant generate trading strategies?

Accepted Answer

You write a natural-language prompt describing your market idea. CommonQuant selects validated instruments, chooses from 20 supported technical indicators, and writes concrete entry and exit rules. The strategy then runs live and sends alerts through the channels available on your plan when conditions trigger.

Question 3

What markets and instruments does CommonQuant support?

Accepted Answer

CommonQuant supports several thousand US equities and ETFs listed on Nasdaq, NYSE, NYSE American, and Cboe, plus major crypto assets such as Bitcoin. It does not support FX or futures.

Question 4

How do I receive trading signal alerts?

Accepted Answer

CommonQuant provides an in-app signal inbox on all plans. Paid plans add email and Telegram, plus metered monthly SMS and WhatsApp allowances. Channel availability and allowances vary by plan.

Question 5

Is CommonQuant free to use?

Accepted Answer

Yes. CommonQuant has a free tier with 1,000 starter credits, 200 monthly refill credits, up to three signal subscriptions, and in-app alerts. Paid plans start at $9/month, and no credit card is required to start.

Question 6

Does CommonQuant provide financial advice?

Accepted Answer

No. CommonQuant is a quantitative tool for alpha validation and does not constitute financial advice. Past performance does not guarantee future results. Users are responsible for their own trading decisions.

Question 7

Can I copy public trading strategies?

Accepted Answer

Yes. Users can browse, preview, and copy public community and AI-generated strategies into their own accounts. They can also follow strategists and take part in Arena competitions.

NUVA Trade Ideas

Recent trade ideas mentioning NUVA

GSK is reportedly buying Nuvalent for $9B — trade the takeover premium